0
     

Report Added
Report already added
Alzheimer's Disease Market - Global Outlook and Forecast 2022-2028

Alzheimer's Disease Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Alzheimer's Disease in Global, including the following market information:

Global Alzheimer's Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Alzheimer's Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Donepezil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alzheimer's Disease include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer's Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Alzheimer's Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Alzheimer's Disease Market Segment Percentages, by Type, 2021 (%)
Donepezil
Memantine
Rivastigmine
Global Alzheimer's Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Alzheimer's Disease Market Segment Percentages, by Application, 2021 (%)
Early to Moderate Stages
Moderate to Severe Stages
Global Alzheimer's Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Alzheimer's Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer's Disease revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Alzheimer's Disease revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Alzheimer's Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer's Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer's Disease Overall Market Size
2.1 Global Alzheimer's Disease Market Size: 2021 VS 2028
2.2 Global Alzheimer's Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alzheimer's Disease Players in Global Market
3.2 Top Global Alzheimer's Disease Companies Ranked by Revenue
3.3 Global Alzheimer's Disease Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer's Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alzheimer's Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Players in Global Market
3.6.1 List of Global Tier 1 Alzheimer's Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Alzheimer's Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Alzheimer's Disease Market Size Markets, 2021 & 2028
4.1.2 Donepezil
4.1.3 Memantine
4.1.4 Rivastigmine
4.2 By Type - Global Alzheimer's Disease Revenue & Forecasts
4.2.1 By Type - Global Alzheimer's Disease Revenue, 2017-2022
4.2.2 By Type - Global Alzheimer's Disease Revenue, 2023-2028
4.2.3 By Type - Global Alzheimer's Disease Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alzheimer's Disease Market Size, 2021 & 2028
5.1.2 Early to Moderate Stages
5.1.3 Moderate to Severe Stages
5.2 By Application - Global Alzheimer's Disease Revenue & Forecasts
5.2.1 By Application - Global Alzheimer's Disease Revenue, 2017-2022
5.2.2 By Application - Global Alzheimer's Disease Revenue, 2023-2028
5.2.3 By Application - Global Alzheimer's Disease Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Alzheimer's Disease Market Size, 2021 & 2028
6.2 By Region - Global Alzheimer's Disease Revenue & Forecasts
6.2.1 By Region - Global Alzheimer's Disease Revenue, 2017-2022
6.2.2 By Region - Global Alzheimer's Disease Revenue, 2023-2028
6.2.3 By Region - Global Alzheimer's Disease Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Alzheimer's Disease Revenue, 2017-2028
6.3.2 US Alzheimer's Disease Market Size, 2017-2028
6.3.3 Canada Alzheimer's Disease Market Size, 2017-2028
6.3.4 Mexico Alzheimer's Disease Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Alzheimer's Disease Revenue, 2017-2028
6.4.2 Germany Alzheimer's Disease Market Size, 2017-2028
6.4.3 France Alzheimer's Disease Market Size, 2017-2028
6.4.4 U.K. Alzheimer's Disease Market Size, 2017-2028
6.4.5 Italy Alzheimer's Disease Market Size, 2017-2028
6.4.6 Russia Alzheimer's Disease Market Size, 2017-2028
6.4.7 Nordic Countries Alzheimer's Disease Market Size, 2017-2028
6.4.8 Benelux Alzheimer's Disease Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Alzheimer's Disease Revenue, 2017-2028
6.5.2 China Alzheimer's Disease Market Size, 2017-2028
6.5.3 Japan Alzheimer's Disease Market Size, 2017-2028
6.5.4 South Korea Alzheimer's Disease Market Size, 2017-2028
6.5.5 Southeast Asia Alzheimer's Disease Market Size, 2017-2028
6.5.6 India Alzheimer's Disease Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Alzheimer's Disease Revenue, 2017-2028
6.6.2 Brazil Alzheimer's Disease Market Size, 2017-2028
6.6.3 Argentina Alzheimer's Disease Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alzheimer's Disease Revenue, 2017-2028
6.7.2 Turkey Alzheimer's Disease Market Size, 2017-2028
6.7.3 Israel Alzheimer's Disease Market Size, 2017-2028
6.7.4 Saudi Arabia Alzheimer's Disease Market Size, 2017-2028
6.7.5 UAE Alzheimer's Disease Market Size, 2017-2028
7 Players Profiles
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Alzheimer's Disease Major Product Offerings
7.1.4 Allergan Alzheimer's Disease Revenue in Global Market (2017-2022)
7.1.5 Allergan Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Alzheimer's Disease Major Product Offerings
7.2.4 Eisai Alzheimer's Disease Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Alzheimer's Disease Major Product Offerings
7.3.4 Novartis Alzheimer's Disease Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Corporate Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Alzheimer's Disease Major Product Offerings
7.4.4 Daiichi Sankyo Alzheimer's Disease Revenue in Global Market (2017-2022)
7.4.5 Daiichi Sankyo Key News
7.5 Merz Pharma
7.5.1 Merz Pharma Corporate Summary
7.5.2 Merz Pharma Business Overview
7.5.3 Merz Pharma Alzheimer's Disease Major Product Offerings
7.5.4 Merz Pharma Alzheimer's Disease Revenue in Global Market (2017-2022)
7.5.5 Merz Pharma Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Alzheimer's Disease Major Product Offerings
7.6.4 Pfizer Alzheimer's Disease Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Alzheimer's Disease Major Product Offerings
7.7.4 Johnson & Johnson Alzheimer's Disease Revenue in Global Market (2017-2022)
7.7.5 Johnson & Johnson Key News
7.8 Lundbeck
7.8.1 Lundbeck Corporate Summary
7.8.2 Lundbeck Business Overview
7.8.3 Lundbeck Alzheimer's Disease Major Product Offerings
7.8.4 Lundbeck Alzheimer's Disease Revenue in Global Market (2017-2022)
7.8.5 Lundbeck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Alzheimer's Disease Market Opportunities & Trends in Global Market
Table 2. Alzheimer's Disease Market Drivers in Global Market
Table 3. Alzheimer's Disease Market Restraints in Global Market
Table 4. Key Players of Alzheimer's Disease in Global Market
Table 5. Top Alzheimer's Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alzheimer's Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alzheimer's Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alzheimer's Disease Product Type
Table 9. List of Global Tier 1 Alzheimer's Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alzheimer's Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alzheimer's Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alzheimer's Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alzheimer's Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alzheimer's Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alzheimer's Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alzheimer's Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alzheimer's Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alzheimer's Disease Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Alzheimer's Disease Product Offerings
Table 32. Allergan Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Alzheimer's Disease Product Offerings
Table 35. Eisai Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Alzheimer's Disease Product Offerings
Table 38. Novartis Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 39. Daiichi Sankyo Corporate Summary
Table 40. Daiichi Sankyo Alzheimer's Disease Product Offerings
Table 41. Daiichi Sankyo Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 42. Merz Pharma Corporate Summary
Table 43. Merz Pharma Alzheimer's Disease Product Offerings
Table 44. Merz Pharma Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Alzheimer's Disease Product Offerings
Table 47. Pfizer Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Alzheimer's Disease Product Offerings
Table 50. Johnson & Johnson Alzheimer's Disease Revenue (US$, Mn), (2017-2022)
Table 51. Lundbeck Corporate Summary
Table 52. Lundbeck Alzheimer's Disease Product Offerings
Table 53. Lundbeck Alzheimer's Disease Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Alzheimer's Disease Segment by Type in 2021
Figure 2. Alzheimer's Disease Segment by Application in 2021
Figure 3. Global Alzheimer's Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alzheimer's Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alzheimer's Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer's Disease Revenue in 2021
Figure 8. By Type - Global Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 12. US Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 16. Germany Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 24. China Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alzheimer's Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alzheimer's Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Daiichi Sankyo Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merz Pharma Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lundbeck Alzheimer's Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Alzheimer's Disease Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027